Roman vs. MadeMed for ED (2026): Standard Pills or a 3-in-1 Troche?
Roman offers a broad treatment ladder. MadeMed leads with one distinctive compounded proposition: a troche combining tadalafil, PT-141, and oxytocin.
Roman
Online clinician review with access, when prescribed, to sildenafil, tadalafil, brand-name options, and Roman-specific compounded formats such as Ro Sparks.
Eligibility and treatment choice are determined by a licensed clinician. Roman also offers compounded products; compounded drugs are not FDA-approved.
See Roman ED OptionsMadeMed
A telehealth product centered on a compounded troche combining tadalafil, PT-141, and oxytocin, subject to clinician review.
The combination product is compounded and not FDA-approved. Evidence and approved-use context differ across its ingredients.
See MadeMedRoman vs. MadeMed at a glance
| Factor | Roman | MadeMed |
|---|---|---|
| Core ED menu | Sildenafil, tadalafil, brand options, Sparks, Daily Rise | Compounded tadalafil + PT-141 + oxytocin troche |
| Regulatory mix | Approved finished drugs and compounded products | Featured combination product is compounded and not FDA-approved |
| Treatment scope | Broad ladder from standard tablets to alternative formats | Narrower combination-product proposition |
| Mechanism emphasis | Primarily PDE5 inhibition, including a two-PDE5 combination in Sparks | Blood flow plus centrally acting and intimacy-oriented ingredient claims |
| Pricing presentation | Detailed public Ro table | MadeMed lists a starting monthly price; dose and plan determine total |
| Best fit | Someone who wants to start simple or compare multiple formats | Someone with a clinician-supported reason to consider the exact combination |
The formulas are not direct equivalents
Roman’s standard sildenafil and tadalafil products are single-ingredient PDE5 inhibitor treatments. Ro Sparks combines two PDE5 inhibitors: sildenafil and tadalafil. MadeMed combines tadalafil with PT-141 and oxytocin, ingredients promoted as addressing desire and intimacy in addition to blood flow.
Those narratives should not be mistaken for equal evidence across every ingredient and outcome. Tadalafil is established for ED. PT-141, or bremelanotide, has an FDA-approved product for a different population and indication; its use in a male ED compound is not the same approved use. Oxytocin marketing often extends beyond strong clinical proof for erectile function. A clinician should explain the evidence and uncertainty rather than merely count mechanisms.
Why starting simple often matters
When a patient has not tried an ordinary PDE5 inhibitor, a standard single-ingredient option provides a clearer test of benefit and tolerability. If a three-ingredient product causes nausea, flushing, headache, blood-pressure effects, or no improvement, it is harder to know which ingredient contributed.
A combination can be reasonable when a prescriber has a specific rationale, but “three in one” is not a clinical outcome. Ask what problem each ingredient is intended to solve, what evidence supports that use in men with ED, and what simpler alternative was considered.
Pricing and value
MadeMed’s current sexual-health page advertises the combination from a monthly starting price. Roman’s prices vary widely from generic sildenafil to brand-name products and Sparks. The useful comparison is not simply monthly fee versus monthly fee. Compare number of doses, exact strengths, refill commitment, and whether a simpler generic would meet the same goal.
Combination compounding commands a premium because it is a differentiated product. That premium is economically justified only when the differentiated formula adds practical value for the individual patient.
Compounded-product questions
Both Ro Sparks and MadeMed’s troche are compounded finished products. FDA does not approve compounded drugs or verify their finished-product safety, effectiveness, or quality before marketing. Ask for the compounding pharmacy, ingredient strengths, beyond-use date, storage conditions, and reason the formulation is appropriate.
Do not describe either product as a generic version of an approved combination, because there is no approved finished equivalent of these multi-ingredient formulas.
Who fits each provider?
- Roman: a patient who wants a standard starting option, brand or generic choice, or access to several formats in one service.
- MadeMed: a patient specifically evaluated for its three-ingredient troche and comfortable with the evidence and compounding uncertainties.
- Neither without further workup: new ED with cardiovascular symptoms, severe low desire, hormonal symptoms, penile pain or curvature, or failure of properly used standard therapy.
Combination products require extra medication reconciliation
PDE5 inhibitors such as sildenafil and tadalafil are prescription drugs. They are not appropriate for everyone, and they can interact dangerously with nitrates used for chest pain. A clinician should review your cardiovascular history, blood pressure, other medications, and the pattern of your symptoms. Seek urgent care for an erection lasting more than four hours, and seek medical attention for sudden vision or hearing changes.
ED can also be a sign of an underlying vascular, neurologic, hormonal, medication-related, or psychological issue. An online prescription can be convenient, but convenience should not replace a proper evaluation when symptoms are new, worsening, painful, associated with penile curvature, or accompanied by other concerning symptoms.
Tell the prescriber about every ED drug, blood-pressure drug, nitrate, alpha blocker, psychiatric medication, supplement, and recreational substance. Never stack Roman and MadeMed products.
Frequently asked questions
Is MadeMed’s 3-in-1 troche FDA-approved?
No. It is a compounded finished product. The regulatory status and evidence differ across its ingredients.
Is Ro Sparks the same as MadeMed?
No. Sparks contains sildenafil and tadalafil. MadeMed’s featured troche contains tadalafil, PT-141, and oxytocin.
Does more active ingredients mean a stronger ED treatment?
Not necessarily. It can mean more mechanisms, interactions, side effects, and uncertainty. Benefit must be established for the individual patient.
Which is better for someone new to ED medication?
A clinician may prefer a standard single-ingredient treatment first because response and side effects are easier to interpret, but the decision is individualized.
Keep comparing
Primary sources checked
- Roman ED treatment overview
- Ro Sparks product page
- Ro pricing page
- MadeMed sexual-health treatment page
- FDA questions and answers on drug compounding
- FDA guidance for telehealth companies promoting compounded drugs
- NIDDK treatment for erectile dysfunction
Provider menus and prices can change. This page was checked on 2026-07-24; verify current terms before purchasing.